AZZ News

Latest AZZ News

• Jazz Advances Early JZP269 Study as Investors Await Safety Data
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 4, 2026
• Jazz’s Epidyolex Follow-Up Study Reaches Completion: What It Means for JAZZ Investors
  TipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 3, 2026
• Analysts Are Bullish on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ)
  TipRanks Newsroom · Nov 3, 2026
• Piper Sandler Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)
  TipRanks Auto-Generated Intelligence Newsdesk · Nov 3, 2026
• Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and Alcon (ALC)
  TipRanks Newsroom · Nov 3, 2026
• Analysts Offer Insights on Healthcare Companies: Innovent Biologics (OtherIVBXF), Jazz Pharmaceuticals (JAZZ) and Inspire Medical Systems (INSP)
  TipRanks Newsroom · Nov 3, 2026
• Aztec Minerals Bolsters Technical Team as Tombstone Resource Work Accelerates
  TipRanks Canadian Auto-Generated Newsdesk · Oct 30, 2026
• AZZ (AZZ) Receives a Hold from Barclays
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 27, 2026
• AZZ Highlights Growth Prospects in New Investor Presentation
  TipRanks Auto-Generated Newsdesk · Oct 26, 2026
• Aztec Minerals Extends Oxide Gold-Silver Footprint at Tombstone Project
  TipRanks Canadian Auto-Generated Newsdesk · Oct 22, 2026
• Positive Report for Azzas 2154 SA (AZZA3) from Citi
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 20, 2026
• Positive Report for Azzas 2154 SA (AZZA3) from Citi
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 20, 2026
• Analysts’ Top Healthcare Picks: Revolution Medicines (RVMD), Jade Biosciences (JBIO)
  TipRanks Newsroom · Oct 16, 2026
• Barclays Keeps Their Buy Rating on Jazz Pharmaceuticals (JAZZ)
  TipRanks Auto-Generated Intelligence Newsdesk · Oct 13, 2026